Fabian Gerlinghaus, Cellares CEO and president Omar Kurdi at the company's facility in South San Francisco
Exclusive: Cellares expands deal with Bristol Myers on CAR-T asset, eyes manufacturing expansion
Cellares has expanded its partnership deal with Bristol Myers Squibb to assist the Big Pharma in developing another unnamed CAR-T cell therapy via its cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.